Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/1998
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875511A1 Demethylation process for preparing benzo[b]thiophenes
11/04/1998EP0875506A1 Quinoline and quinazoline compounds useful in therapy
11/04/1998EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998EP0874637A1 Therapeutic applications of t-bam (cd40l) technology to treat inflammatory kidney diseases
11/04/1998EP0874627A1 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors
11/04/1998EP0874622A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
11/04/1998EP0705244B1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
11/04/1998CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830686 Gene expression
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998CA1340112C Supression of cell proliferation by decorin
10/1998
10/30/1998CA2236254A1 Process for preparing benzo¬b|thiophenes
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048054A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998WO1998047898A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998CA2287571A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998CA2286106A1 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/28/1998EP0873751A2 Pharmaceutical product for application to uterus mucosa
10/28/1998EP0873407A1 Apo-2 ligand
10/28/1998EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0716648B1 New 9-chloro-prostaglandin derivatives
10/28/1998CN1197076A Steroid compounds having contraceptive and anti-osteoporosis activity
10/28/1998CN1196936A Medicament for treating primary glomerular disease and its prepn. method
10/28/1998CN1196930A Drug delivery system for twor or more active substance
10/28/1998CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998US5827892 Treatment and prevention of atherosclerosis
10/27/1998US5827887 Biphenyl compounds
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/22/1998WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998WO1998046743A1 Novel ldl-receptor
10/22/1998WO1998046589A2 Indazole amide compounds as serotoninergic agents
10/22/1998WO1998046237A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998WO1998046076A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
10/22/1998WO1998034949A3 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
10/22/1998CA2286351A1 Extracellular/epidermal growth factor like protein
10/22/1998CA2285950A1 Method of treating chronic progressive vascular scarring diseases
10/21/1998EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998EP0872231A1 Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration
10/21/1998EP0871667A1 G-protein coupled receptor
10/21/1998EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998EP0871624A1 Antagonists of gonadotropin releasing hormone
10/21/1998EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998EP0871443A1 Advanced glycation end-product intermediaries and post-amadori inhibition
10/21/1998EP0871363A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
10/21/1998EP0752871A4 Adhesion inhibiting composition
10/21/1998CN1196680A Endothelin receptor antagonists
10/21/1998CN1196256A Medicine for preventing and curing cardiovascular disease, treating prostatic hyperplasia and preparation method thereof
10/21/1998CN1040321C Pyran-2-ones and 5,6-dihydropyran-2-ones, medicine composition containing them and pharmacy use thereof
10/20/1998US5824691 Guanidine derivatives as inhibitors of Na+ /H+ exchange in cells
10/20/1998US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/15/1998WO1998045427A2 Insulin-like growth factor agonist peptides
10/15/1998WO1998045420A1 Pca3, pca3 genes, and methods of use
10/15/1998WO1998045292A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties
10/15/1998WO1998045291A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
10/15/1998WO1998045288A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998WO1998045257A1 Thio derivatives as naaladase inhibitors
10/15/1998WO1998045256A1 Hydroxamic acid derivatives
10/15/1998WO1998044937A1 Preventive or remedy for kidney diseases
10/15/1998WO1998029105A3 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
10/15/1998CA2286264A1 Insulin-like growth factor agonist peptides
10/15/1998CA2286204A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998CA2285906A1 Hydroxamic acid derivatives
10/15/1998CA2285900A1 Prophylactics and remedies for renal diseases
10/15/1998CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/14/1998EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998EP0869957A2 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds
10/14/1998EP0869946A1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/14/1998EP0869788A1 Compositions for the treatment of renal failure, comprising l-carnosine
10/14/1998EP0856312B1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder
10/14/1998EP0806947A4 Formulations and methods for reducing skin irritation
10/14/1998CN1195993A Intranasal vaccination against gastrointestinal disease
10/14/1998CN1195984A Pharmaceutical formulations containing darifenacin
10/14/1998CN1195666A Intermediates of steroids, their preparation and uses
10/13/1998US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998US5821256 Endothelin receptor antagonists
10/13/1998US5821255 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
10/13/1998US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections
10/13/1998US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998US5820587 Method and kit for preventing erectile dysfunction
10/08/1998WO1998044128A1 Novel human serine carboxypeptidase
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 562